# EDGAR Filing Document

**Accession Number:** 0001896212
**File Stem:** 0001753926-26-000581
**Filing Date:** 2026-3
**Character Count:** 16549
**Document Hash:** 7d6bb51cbde43f00591271c0af0141d0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001753926-26-000581.hdr.sgml**: 20260330

**ACCESSION NUMBER**: 0001753926-26-000581

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D

**PUBLIC DOCUMENT COUNT**: 3

**FILED AS OF DATE**: 20260330

**DATE AS OF CHANGE**: 20260330

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CDT Equity Inc.
- **CENTRAL INDEX KEY:** 0001896212
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 873272543
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-93313
- **FILM NUMBER:** 26816487

**BUSINESS ADDRESS:**
- **STREET 1:** 4851 TAMIAMI TRAIL NORTH
- **STREET 2:** SUITE 200
- **CITY:** NAPLES
- **STATE:** FL
- **ZIP:** 34103
- **BUSINESS PHONE:** (646) 491 9132

**MAIL ADDRESS:**
- **STREET 1:** 4851 TAMIAMI TRAIL NORTH
- **STREET 2:** SUITE 200
- **CITY:** NAPLES
- **STATE:** FL
- **ZIP:** 34103

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CONDUIT PHARMACEUTICALS INC.
- **DATE OF NAME CHANGE:** 20230922

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Murphy Canyon Acquisition Corp.
- **DATE OF NAME CHANGE:** 20211130
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Taylor Mark Andrew
- **CENTRAL INDEX KEY:** 0002119432

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 418 SPEARGRASS FLAT ROAD
- **CITY:** QUEENSTOWN
- **PROVINCE COUNTRY:** Q2
- **ZIP:** 00000

## Exhibit 99.1

Exhibit 99.1

**JOINT FILING AGREEMENT**

**PURSUANT TO RULE 13d-1(k)**

The undersigned acknowledge and agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13D shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained herein and therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate. The undersigned hereby further agree that this Joint Filing Agreement may be executed in any number of counterparts, each of which when so executed shall be deemed to be an original, but all of which counterparts shall together constitute one and the same instrument.

---

| | | |
|:---|:---|:---|
| Date: 03/30/2026 |  |  |
|  | **Mark Taylor** | **Mark Taylor** |
|  | <u>/s/ Mark Taylor</u> | <u>/s/ Mark Taylor</u> |
|  | **Prospect Capital Securities Limited** | **Prospect Capital Securities Limited** |
|  | By: | /s/ Mark Taylor |
|  |  | Name: Mark Taylor |
|  |  | Title: Director<br>|
|  | **Prospect Finance Limited** | **Prospect Finance Limited** |
|  | By: | /s/ Mark Taylor |
|  |  | Name: Mark Taylor |
|  |  | Title: Director |

---

## Exhibit 99.4

Exhibit 99.4

**SCHEDULE I**

**SCHEDULE OF TRANSACTIONS IN SHARES**

The following table sets forth all transactions in the shares of Common Stock effected in the past sixty days by the Reporting Persons.

---

| | | | | |
|:---|:---|:---|:---|:---|
| Trade Date | Reporting Person | Type | Shares | Price Per Share ($)<sup>(1)</sup> |
| 2/19/2026 | Prospect Capital Securities Limited | Acquisition of Common Stock from Issuer | 198749 | – |
| 2/19/2026 | Prospect Finance Limited | Acquisition of Common Stock from Issuer | 127209 | – |
| 2/19/2026 | Prospect Finance Limited | Transfer of Common Stock to third party | 46902 | – <sup>(2)</sup> |
| 2/19/2026 | Prospect Capital Securities Limited | Acquisition of Pre-Funded Warrant from Issuer | 36551817 | – |
| 2/19/2026 | Prospect Finance Limited | Acquisition of Pre-Funded Warrant from Issuer | 24578432 | – |
| 2/19/2026 | Prospect Finance Limited | Transfer of Pre-Funded Warrant to third party | 9968931 | – <sup>(2)</sup> |
| 3/17/2026 | Prospect Capital Securities Limited | Acquisition of Common Stock on Pre-Funded Warrant Exercise | 36544028 | – <sup>(3)</sup> |
| 3/17/2026 | Prospect Finance Limited | Acquisition of Common Stock on Pre-Funded Warrant Exercise | 14876330 | – <sup>(3)</sup> |

---

(1) The information contained in Item 3 of the Schedule 13D to which this Schedule I is attached is incorporated herein by reference.

(2) Transferred for no consideration.

(3) Exercised pursuant to the "cashless" exercise provision of the Pre-Funded Warrant.

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**CDT Equity Inc.**

*(Name of Issuer)*

**Common Stock, par value $0.0001 per share**

*(Title of Class of Securities)*

**—**

*(CUSIP Number)*

**Mark Taylor**<br>418 Speargrass Flat Road<br>Queenstown Q2 9371<br>64-21-68 1231

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**02/19/2026**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Taylor Mark Andrew** | Name of reporting person<br>**Taylor Mark Andrew** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**Q2** | Citizenship or place of organization<br>**Q2** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**51700014.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**51700014.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**51700014.00** | Aggregate amount beneficially owned by each reporting person<br>**51700014.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**43.79%** | Percent of class represented by amount in Row (11)<br>**43.79%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IV** | Type of Reporting Person (See Instructions)<br>**IV** | |

---

**Comment for Reporting Person:** The percentage ownership of shares of common stock, par value $0.0001 per share (the "Common Stock"), of CDT Equity Inc., a Delaware corporation (the "Issuer"), set forth in this Schedule 13D (the "Schedule 13D") is based upon 118,061,466 shares of Common Stock outstanding as of March 19, 2026, as independently confirmed by the Issuer.

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Prospect Capital Securities Ltd** | Name of reporting person<br>**Prospect Capital Securities Ltd** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**Q2** | Citizenship or place of organization<br>**Q2** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**36742777.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**36742777.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**36742777.00** | Aggregate amount beneficially owned by each reporting person<br>**36742777.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**31.12%** | Percent of class represented by amount in Row (11)<br>**31.12%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**OO** | Type of Reporting Person (See Instructions)<br>**OO** | |

---

**Comment for Reporting Person:** The percentage ownership of shares of Common Stock set forth in this Schedule 13D is based upon 118,061,466 shares of Common Stock outstanding as of March 19, 2026, as independently confirmed by the Issuer.

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Prospect Finance Ltd** | Name of reporting person<br>**Prospect Finance Ltd** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**Q2** | Citizenship or place of organization<br>**Q2** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**14957237.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**14957237.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**14957237.00** | Aggregate amount beneficially owned by each reporting person<br>**14957237.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**12.67%** | Percent of class represented by amount in Row (11)<br>**12.67%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**OO** | Type of Reporting Person (See Instructions)<br>**OO** | |

---

**Comment for Reporting Person:** The percentage ownership of shares of Common Stock set forth in this Schedule 13D is based upon 118,061,466 shares of Common Stock outstanding as of March 19, 2026, as independently confirmed by the Issuer.

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock, par value $0.0001 per share

**(b) Name of Issuer:**
CDT Equity Inc.

**(c) Address of Issuer's Principal Executive Offices:**
4851 Tamiami Trail North, Suite 200, Naples, FL, 34103

This Schedule 13D (this "Schedule 13D") relates to the common stock, par value $0.0001 per share (the "Common Stock"), of CDT Equity Inc., a Delaware corporation (the "Issuer"). The principal executive office of the Issuer is located at 4851 Tamiami Trail North, Suite 200, Naples, Florida 34103

**Item 4. Purpose of Transaction**

Prospect Capital and Prospect Finance acquired the shares of Common Stock and Pre-Funded Warrants reported herein in connection with the Purchase Agreement for investment purposes. The information contained in Item 3 of this Schedule 13D is incorporated herein by reference.

**Item 5. Interest in Securities of the Issuer**

**(a)**
The percentage ownership of shares of Common Stock set forth in this Schedule 13D is based upon 118,061,466 shares of Common Stock outstanding as of March 19, 2026, as verified with the Issuer.

Prospect Capital owns directly 36,742,777 shares of Common Stock, which represented approximately 31.12% of the issued and outstanding shares of Common Stock as of March 19, 2026.

Prospect Finance owns directly 14,957,237 shares of Common Stock, which represented approximately 12.67% of the issued and outstanding shares of Common Stock as of March 19, 2026.

Mr. Taylor does not directly own any shares of Common Stock. Mr. Taylor is the sole director and sole shareholder of each of Prospect Capital and Prospect Finance, and as such has shared voting and dispositive power over the shares of Common Stock held by them. By virtue of these relationships, Mr. Taylor may be deemed to beneficially own the shares of Common Stock held of record by each of Prospect Capital and Prospect Finance, which represented approximately 43.79% of the issued and outstanding shares of Common Stock as of March 19, 2026. Mr. Taylor disclaims any such beneficial ownership except to the extent of his pecuniary interest therein.

**(b)**
Prospect Capital:  Sole power to vote or to direct the vote:                0
Shared power to vote or to direct the vote:                           36,742,777
Sole power to dispose or to direct the disposition of:                         0
Shared power to dispose or to direct the disposition of:     36,742,777

Prospect Finance:
Sole power to vote or to direct the vote:                                             0
Shared power to vote or to direct the vote:                         14,957,237
Sole power to dispose or to direct the disposition of:                       0
Shared power to dispose or to direct the disposition of:  14,957,237

Mr. Taylor:
Sole power to vote or to direct the vote:                                                 0
Shared power to vote or to direct the vote:                            51,700,014
Sole power to dispose or to direct the disposition of:                          0
Shared power to dispose or to direct the disposition of:      51,700,014

**(c)**
Except as set forth in Schedule I of this Schedule 13D, the Reporting Persons have not engaged in any transaction with respect to the Common Stock during the sixty days prior to the date of filing this Schedule 13D.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

The information set forth in Items 3 and 4 with respect to the Purchase Agreement and the Pre-Funded Warrants is incorporated herein by reference.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Taylor Mark Andrew

**Signature:** /s/ Mark Taylor

**Name/Title:** Mark Taylor

**Date:** 03/30/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Prospect Capital Securities Ltd

**Signature:** /s/ Mark Taylor

**Name/Title:** Mark Taylor, Director

**Date:** 03/30/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Prospect Finance Ltd

**Signature:** /s/ Mark Taylor

**Name/Title:** Mark Taylor, Director

**Date:** 03/30/2026